Pelvic Floor Diagnostics Market

Pelvic Floor Diagnostics Market Snapshot (2023 to 2033)

The overall valuation of the pelvic floor diagnostics market is projected to total USD 2,056.74 million in 2023. By the end of 2033, the market is estimated to equal USD 3,753.39 million, recording a CAGR of 6.2%.

The report also forecasts that the demand for uroflowmetry devices and anal manometry systems is expected to rise at 8.2% CAGR through the assessment period.

The growth of the pelvic floor diagnostics industry is primarily associated with the growing prevalence of pelvic floor disorders globally and rising healthcare expenditure. The developments of technologically advanced diagnostic systems and government support have led to a surge in demand for reliable and extensive diagnostic systems.

Improvements in reimbursement structures have led manufacturers to invest in the pelvic floor diagnostic sector creating a conducive environment for growth through 2033.

Attributes	Details
Pelvic Floor Diagnostics Market Size (2023)	USD 2,056.74 million
Pelvic Floor Diagnostics Market Size (2033)	USD 3,753.39 million
Pelvic Floor Diagnostics Market CAGR (2023 to 2033)	6.2%
Pelvic Floor Diagnostics Industry Size (2022)	USD 1,936.66 million

Following Factors Set Forth Market Development:

• The continued increase in human pelvic floor anomalies and their subsequent diagnostics propel market development. Some commonly observed pelvic floor disorders include constipation, fecal incontinence, and pelvic organ prolapse.
• Technological upgradation in diagnostic devices of anorectal manometry systems is facilitating the healthcare sector to better provide for existing and emerging patients.
• Obesity is linked with pelvic floor disorders. Obesity adds extra weight to the abdomen, which puts strain on pelvic floor muscles. This strain weakens the associated muscles and causes incontinence. The obese population is prone to bowel, fecal incontinence, urinary, and sexual dysfunction problems. Thus, the rapid increase in the obese population is favoring market growth.
• Poor lifestyle habits and unassessed dietary intake result in lifestyle disorders of the urinary tract or surrounding region. As a result, increasing the diagnostics for the pelvic floor region.
• Increasing funding by key players to research and develop efficient diagnostics and boost awareness regarding the associated diseases. This is projected to stimulate market growth.
• The surge in government campaigns to raise awareness among women regarding pelvic floor disorders is also spurring market development.

Market Studded with Emerging Opportunities

• The equipment required to efficiently diagnose pelvic floor disorders is expensive. To deal with this issue, market participants are focusing their efforts on acquiring local or smaller players to magnify their customer base. Additionally, by integrating the technology of the acquired firm, the acquiring companies are improving their offerings.
• Another way key players are grabbing the upcoming opportunities includes exclusive partnerships with regional distributors. Players are also marketing their products to attract more customers and repeat utilization by existing ones. The companies are also delivering technical training for deployment and handling of their equipment.

Key Factors Instigating Obstacles in Market Development

• Insufficient awareness among expectant mothers and the general public regarding pelvic floor issues is hampering the market growth. A large proportion of women do not seek medical advice or assistance owing to the stigma associated with these issues. Governments are, however, working in unity with other organizations to dispel the stigma related to these problems by educating the masses.
• The unaffordability of equipment like anorectal manometry systems and the high costs associated with obtaining and maintaining such equipment dissuade end users from investing in them.

2018 to 2022 Pelvic Floor Diagnostics Market Outlook Compared to 2023 to 2033 Forecast

The pelvic floor diagnostics industry is expected to rise at a CAGR of 6.2% between 2023 and 2033 in comparison to the 3.5% CAGR registered from 2018 to 2022. This growth is highly associated with factors such as growing healthcare expenditure and rising technological advancements in the pelvic floor diagnostic sectors.

The prevalence of pelvic floor disorders, especially among pregnant women, and growing awareness for early diagnosis have further propelled sales of pelvic floor diagnostics systems. Growing research and development activities in the field have been supported by financial grants through key players and led to innovative disease control breakthroughs.

Rising awareness among women and men about early diagnosis has led to the increased setup of diagnostic imaging centers. There is a surge in demand for ultrasound imaging systems for high-resolution imaging over radiological methods.

The rise in healthcare spending and growing funding associated with favorable reimbursement has led manufacturers to invest in medical devices. This has resulted in increased adoption of pelvic floor diagnostics along with the growth of other related markets, such as treating pelvic floor prolapse and other dysfunctions.

Country-wise Insights

How is the Pelvic Floor Diagnostics Market Faring in the United States?

The United States dominates the market for pelvic floor diagnostics and is expected to witness steady growth during the forecast period, according to Future Market Insights. The analysis estimates that the United States is expected to account for a market share of 81.5% in North America in 2023.

The growth of the pelvic floor diagnostics industry in the country is characterized by the rising prevalence rate of pelvic floor disorders among pregnant women and the subsequent rise in healthcare expenditure.

Why is the Demand for Pelvic Floor Diagnostics Increasing in the United Kingdom?

Country	The United Kingdom
Forecast CAGR % (2023 to 2033)	5.8%

The United Kingdom pelvic floor diagnostics industry is expected to witness a CAGR of 5.8% over the forecast period. Government support and funding have promoted demand. The rapid increase in the geriatric population is a primary factor leading to an increase in pelvic floor disorders.

According to estimates conducted by the UNU (United Nations University), the percentage of geriatrics above 65 years of age is expected to rise to 16% by 2050 from 7% in 2000. A study conducted in 2005 by the World Health Organization determined that one of the significant factors leading to urinary incontinence in women is aging, which is also projected to support sales prospects.

What is the Outlook of the Brazil Pelvic Floor Diagnostics Market?

Country	Brazil
Forecast CAGR % (2023 to 2033)	5.5%

Brazil holds a current market share of more than 48.9% of the revenue generated in Latin America in 2023. According to the analysis by Future Market Insights, the country is expected to present highly lucrative growth with a CAGR of 5.5% over the forecast period.

Brazil is expected to support profitable growth due to the increasing prevalence of pelvic floor disorders such as overactive bladders and urinary incontinence among females. In Brazil, estimates of the prevalence of OAB range from 7.6% to 25%, and the rise in government regulations for its treatment.

The use of diagnostic devices and in-clinic diagnostic procedures for pelvic floor diagnosis has seen a proportionate increase along with the rising adoption rates by high-income population groups. The demand for hospitals and diagnostic laboratories for pelvic floor diagnosis has led to growth in the country.

What are the Prospects for Pelvic Floor Diagnostics in Mexico?

In 2022, Mexico accounted for over 38.4% of the market share in Latin America. The moderately steady growth in the country is influenced by the growing demand for various pelvic floor diagnostic testing services.

Pelvic floor diagnosis has been hindered by the topic being considered taboo. Increasing expenditure and growing awareness programs by the government to support the population have led to a rise in the demand for pelvic floor diagnostics in Mexico.

Category-wise Insights

Why are Ultrasound Systems Key to Revenue Generation?

Segment	Ultrasound Systems
Forecast CAGR % (2023 to 2033)	5.7%

The demand for ultrasound systems in the pelvic floor diagnostics market globally is supported by the demand for ultrasound systems over radiological methods. Ultrasound systems amount to a substantial market share of 37.3% as of 2022 and are expected to grow over the forecast period at a CAGR of 5.7%.

The growing advancements in ultrasound systems have triggered a renewed interest in diagnostic imaging in urogynecology and female urology.

What is the Contribution of Hospitals to Pelvic Floor Diagnostics Sales?

Segment	Hospitals
Forecast CAGR % (2023 to 2033)	5.5%

Based on the end user, the hospital segment depicts a significant market share of 64.2% in 2023 and is projected to thrive at a CAGR of 5.5% over the forecast period.

The revenue growth of the hospital segment is projected to account for over USD 2,002.0 million by the end of the forecast period. The change is supported by improving health infrastructure, an increase in experienced physicians, the availability of advanced devices, and rising research and development spending for medical devices.

Competitors and their Strategies

Key pelvic floor diagnostics market players are involved in innovative research and development activities for specialized and efficient diagnostic devices. Leading companies also focus on strategic mergers and acquisitions for geographical expansion and increased market footprint.

• For instance, in March 2021, HOYA Corporation (the parent company of Albyn Medical) signed a five-year contract for technical collaboration and supply of diagnostics ultrasound systems and ultrasound sensors with Hitachi.
• In June 2021, Neusoft Corporation revealed its portfolio of medical imaging for diagnosis, including its NeuAngio 30F high-speed floor-mounted DSA system.
• In April 2021, Analytica Ltd. entered a joint venture with Shijiazhuang Biosphere Pty Ltd. and Hebei Nacol Bio-Technology Co. Ltd. to produce and distribute its Pericoach urinary incontinence device.

Key Players in the Market

• LABORIE Inc.
• CooperSurgical Inc.
• SRS Medical
• Medtronic Plc
• MEDSPIRA
• MEDKONSULT medical technology s.r.o.
• Albyn Medical
• PENTAX Medical
• Olympus Medical Systems
• Stryker's
• EndoMed Systems
• Richard Wolf
• Schölly Fiberoptic
• Zhuhai Seesheen Medical Technology
• KARL STORZ
• Cadwell
• The Prometheus Group
• Neurosoft
• Noraxon USA

Scope of Pelvic Floor Diagnostics Market Report

Attribute	Details
Forecast Period	2023 to 2033
Historical Data Available for	2018 to 2022
Market Analysis	USD million for Value and Volume in ‘000’ Units
Key Regions Covered	North America; Latin America; Europe; East Asia; South Asia; Oceania; the Middle East and Africa
Key Countries Covered	The United States, Canada, Brazil, Mexico, the United Kingdom, Germany, France, Spain, Italy, Russia, India, Thailand, Indonesia, Malaysia, China, Japan, South Korea, Australia, Oceania, GCC Countries, South Africa, Türkiye
Key Segments Covered	Product, End User, and Region
Key Companies Profiled	LABORIE Inc.; CooperSurgical Inc.; SRS Medical; Medtronic Plc; MEDSPIRA; MEDKONSULT medical technology s.r.o.; Albyn Medical; PENTAX Medical; Olympus Medical Systems; Stryker's; EndoMed Systems; Richard Wolf; Schölly Fiberoptic; Zhuhai Seesheen Medical Technology; KARL STORZ; Cadwell; The Prometheus Group; Neurosoft; Noraxon USA
Report Coverage	Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives
Customization & Pricing	Available upon Request

Pelvic Floor Diagnostics Market by Category

By Product:

• Urodynamics Systems
• Uroflowmetry Devices
• Anal Manometry Systems
• Cystoscopes
• Ultrasound Systems
  • Cart/Trolley Based
  • Portable Bladder Ultrasound Systems
• EMG

By End User:

• Hospitals
• Diagnostic Imaging Centers
• Specialty Clinics

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• The Middle East and Africa

Frequently Asked Questions

How much is the Pelvic Floor Diagnostics Industry Projected to Attain by 2033 end?

The pelvic floor diagnostics industry is projected to reach a valuation of USD 3,753.39 million by 2033.

Which are the Top Companies Providing Pelvic Floor Diagnostics?

The Prometheus Group and Neurosoft are the top pelvic floor diagnostics industry players.

Which Country is Expected to Account for Significant Market Share?

The United States is projected to hold a sizeable market share over the forecast period.

At what CAGR is the Pelvic Floor Diagnostics Industry Projected to Grow in the Forecast Period?

The pelvic floor diagnostics industry is projected to record a CAGR of 6.2%.